Clinical Study for HerResolve™ in Detecting the Presence of Endometriosis Among Symptomatic Women of Ages 18-49 Years Considering Laparoscopy

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Endometriosis (EMS) is a common gynecological disease that affects 176 million girls and women globally. EMS affects 5-10% of women and adolescents within the reproductive age range of 15-49 years, and for those facing infertility, this figure may climb up to 50%. EMS can start at the first menstrual period and last until menopause. Shockingly, between 50% and 80% of women grappling with pelvic pain are found to have EMS. The formation of scar tissue (adhesions, fibrosis) within the pelvis and other parts of the body can cause severe pain and lead to infertility.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 49
Healthy Volunteers: t
View:

• Females aged 18 to 49 with mild to severe symptoms of pelvic pain and/or abnormal bleeding.

• Diagnostic laparoscopy is scheduled with histology on any visually suspected endometriosis, and all reports (surgical and pathology) to confirm a positive result. If no visually suspicious endometriotic lesions are seen, biopsies from random areas during the laparoscopy procedure to confirm a negative histopathology result.

• Blood drawn during secretory or proliferative phase of the menstrual cycle

• Provide written informed consent to participate in the study and provide medical history on medications.

Locations
Other Locations
China
Department of Obstetrics & Gynaecology The Chinese University of Hong Kong
RECRUITING
Hong Kong
Contact Information
Primary
Elaine Ng
elaineng@cuhk.edu.hk
35052745
Time Frame
Start Date: 2025-10-14
Estimated Completion Date: 2037-06-01
Participants
Target number of participants: 100
Treatments
Experimental: A non-invasive blood-based test
A non-invasive blood-based test to detect endometriosis as compared to diagnostic laparoscopy
Sponsors
Leads: Chinese University of Hong Kong

This content was sourced from clinicaltrials.gov